HOXA9 and acute myeloid leukemia: To test whether the combined H/M overexpression is also associated with enhanced Syk protein expression in primary human AML samples, we performed immunohistochemical (IHC) analyses for HOXA9, MEIS1, and SYK on a cohort of 115 AML cases (Table S2).